The immunosuppressive effects of low molecular weight chitosan on thymopentin-activated mice bearing H22 solid tumors

Hai-Yu Ji,Chao Liu,Ke-Yao Dai,Juan Yu,An-Jun Liu,Ye-Fu Chen,Hai-yu Ji,Ke-yao Dai,An-jun Liu,Ye-fu Chen
DOI: https://doi.org/10.1016/j.intimp.2021.108008
IF: 5.714
2021-10-01
International Immunopharmacology
Abstract:In the present study, the low molecular weight of chitosan (CS) was prepared and its activity on thymopentin-activated mice bearing H22 solid tumors was further researched. The purity and molecular weight of CS were determined by UV and HPGPC spectra, and its immunosuppressive effects on H22 tumor-bearing mice were evaluated through determination on immune organs, cells and cytokines. Results showed that CS contained little impurities with the average molecular weight of 1.20 × 104 Da. The in vivo antitumor experiments demonstrated that CS facilitated to destroy immune organs (thymuses and spleens), suppress immune cells (lymphocytes, macrophages and NK cells) activities and reduce immune-related cytokines (TNF-α, IFN-γ, IL-2 and IL-4) expressions of H22 tumor-bearing mice even with simultaneous TP5 stimulation. Our data suggested that CS could not be applied to improve immune response in cancer-bearing patients, but might be employed for treatments on autoimmune diseases or organ transplant patients.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?